Medicine & Health

Our brains make maps to help navigate the world. In her latest book, Rebecca Schwarzlose examines how these maps shape our world.

Irene Antony, a neuroscience major in Arts & Sciences at Washington University in St. Louis, won the Trainee Professional Development Award from the Society for Neuroscience.

Researchers at Washington University School of Medicine are joining scientists around the country to conduct a study aimed at understanding how prenatal factors and early life experiences influence brain development and behavior in young children.

Research from the lab of Deanna Barch shows that youth who indicate they have persistent, distressing psychotic-like episodes show impairment in a variety of areas.

Older adults who sleep short or long experienced greater cognitive decline than those who sleep a moderate amount, even when the effects of early Alzheimer’s disease were taken into account, according to a study by researchers at Washington University School of Medicine.

Researchers at Washington University School of Medicine have discovered that an FDA-approved drug acts on support cells in the central nervous system to encourage sensory neurons to regrow after injury.

Researchers at Washington University School of Medicine have identified circuitry in the brain that appears to link pain to negative emotional states. The findings, published in Nature Neuroscience, could lead to new treatments.

The National Institute of Mental Health has awarded Washington University School of Medicine a $12.2 million grant to create a center aimed at advancing research into neurosteroids as treatments for depression and other psychiatric disorders.

Meaghan Creed, assistant professor of anesthesiology at Washington University School of Medicine, received the 2021 Freedman Prize from the Brain & Behavior Research Foundation. The prize recognizes exceptional basic research in mental illness.

Researchers at Washington University School of Medicine, the Mayo Clinic in Rochester, Minn., and The Neuro of McGill University have received a five-year grant expected to total $35.1 million for an extension of a study designed to develop biomarkers that indicate which people with REM sleep behavior disorder will go on to develop neurodegenerative diseases.